The association between cancer-related fatigue and diabetes from pre-chemotherapy to 6 months post-chemotherapy.
The association between cancer-related fatigue and diabetes from pre-chemotherapy to 6 months post-chemotherapy.
复制标题
DOI:
10.1007/s00520-022-07189-x
复制
发表时间:
2022-09
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
To quantify the relationship between diabetes and fatigue from pre-chemotherapy to 6 months post-chemotherapy for women with breast cancer compared to women without a history of cancer (controls). This was a secondary analysis from a nationwide prospective longitudinal study of female patients with breast cancer undergoing chemotherapy and controls. Diabetes diagnosis (yes/no) was obtained at baseline, and cancer-related fatigue was measured using the Multidimensional Fatigue Symptom Inventory (MFSI) pre-, post-, and 6-months post-chemotherapy in patients; controls were assessed at equivalent time points. Repeated measures mixed effects models estimated the association between fatigue and diabetes controlling for cancer (yes/no), body mass index, exercise and smoking habits, baseline anxiety and depressive symptoms, menopausal status, marital status, race, and education. Among 439 patients and 235 controls (52.8±10.5 years old), diabetes was twice as prevalent among patients as controls (11.6% vs. 6.8%). At baseline, diabetes was associated with worse fatigue (4.1±1.7 points, p=0.017). Also, diabetes was associated with clinically meaningful worse fatigue throughout the study period among all participants (5.2±1.9 points, p=0.008) and patients alone (4.5±2.0, p=0.023). For the MFSI subdomains among patients, diabetes was associated with worse general (p=0.005) and mental fatigue (p=0.026). Diabetes was twice as prevalent in women with breast cancer compared to controls, and diabetes was associated with more severe cancer-related fatigue in patients before and after chemotherapy and at 6 months post-chemotherapy. Interventions that address diabetes management may also help address cancer-related fatigue during chemotherapy treatment.
登录
查看更多内容
影响因子:
3.1
作者:
Saligan, Leorey N.;Olson, Karin;Filler, Kristin;Larkin, David;Cramp, Fiona;Sriram, Yennu;Escalante, Carmen P.;del Giglio, Auro;Kober, Kord M.;Kamath, Jayesh;Palesh, Oxana;Mustian, Karen
通讯作者:
Mustian, Karen
影响因子:
3.7
作者:
Jones, Jennifer M.;Olson, Karin;Howell, Doris
通讯作者:
Howell, Doris
影响因子:
6.2
作者:
Dieli-Conwright CM;Wong L;Waliany S;Bernstein L;Salehian B;Mortimer JE
通讯作者:
Mortimer JE
DOI:
10.1037/hea0000652
发表时间:
2018-11
期刊:
Health psychology : official journal of the Division of Health Psychology, American Psychological Association
影响因子:
--
作者:
Bower JE;Wiley J;Petersen L;Irwin MR;Cole SW;Ganz PA
通讯作者:
Ganz PA
影响因子:
1.8
作者:
Hershey DS
通讯作者:
Hershey DS